73 articles
Alan Thompson (neurologist)
Alan J. Thompson (born 1955) is a neurologist at the UCL Institute of Neurology known for multiple sclerosis research, the McDonald criteria, and the MS Severity Score.
Alasdair Coles
Alasdair Coles is a British neurologist and neuroimmunologist at the University of Cambridge who developed alemtuzumab as a treatment for relapsing multiple sclerosis and now leads remyelinating drug trials.
Angela Vincent
Angela Vincent is a British neuroimmunologist and Emeritus Professor at Oxford whose work showed that several neurological diseases, including myasthenia gravis and limbic encephalitis, are caused by antibodies.
Barbara Vickrey
Barbara Grace Vickrey is an American neurologist and health services researcher, chair of neurology at Mount Sinai since 2015, known for the QOLIE-89 epilepsy quality-of-life measure.
Barry G.W. Arnason
Barry G.W. Arnason, also known as Barry G. Arnason (1933–2023), was a Canadian-born neurologist and neuro-immunologist who founded the University of Chicago's neurology department and developed Betaseron for multiple sclerosis.
Bernhard Hemmer
Bernhard Hemmer (born 1963) is a German neurologist and neuroimmunologist who has directed neurology at TUM University Hospital in Munich since 2007, specializing in multiple sclerosis.
Brian G. Weinshenker
Brian G. Weinshenker is an American neurologist and multiple sclerosis researcher who spent 30 years at the Mayo Clinic and is a professor of neurology at UVA Health since 2022.
Bruce Cree
Bruce A. C. Cree is a neurologist and multiple sclerosis researcher at UCSF, where he is Clinical Research Director of the UCSF Multiple Sclerosis Center and led trials of ublituximab and inebilizumab.
Bruce D. Trapp
Bruce D. Trapp is an American neuroscientist who chairs Neurosciences at Cleveland Clinic's Lerner Research Institute, known for the 1998 finding that axons are injured in multiple sclerosis.
Cedric S. Raine
Cedric S. Raine is a British-born neuropathologist who joined Albert Einstein College of Medicine in 1969 and studied how myelin is damaged in multiple sclerosis.
Chris H. Polman
Chris H. Polman is a Dutch neurologist and professor at Amsterdam UMC who led the McDonald criteria revisions for MS diagnosis and the 2006 natalizumab trial.
Christian Confavreux
Christian Confavreux (1949–2013) was a French neurologist and multiple sclerosis researcher, professor of neurology in Lyon, who founded the EDMUS database and led landmark studies of MS progression.
Claudia F. Lucchinetti
Claudia F. Lucchinetti is an American neurologist and neuroimmunologist whose research defined the pathological heterogeneity of multiple sclerosis lesions and aquaporin-4 autoimmunity in neuromyelitis optica.
Daniel S. Reich
Daniel S. Reich is an American neurologist and neuroradiologist who directs the Translational Neuroradiology Section at NIH's NINDS and is known for advanced MRI studies of multiple sclerosis.
David Alastair Compston
David Alastair Compston, also known as David Alastair Standish Compston, is a British neurologist, Professor Emeritus at Cambridge, known for quantifying multiple sclerosis genetics and introducing alemtuzumab therapy.
David C. Poskanzer
David C. Poskanzer was an American neurologist and epidemiologist at Massachusetts General Hospital and Harvard Medical School, known for his 1971 paper linking DES exposure to vaginal cancer.
David Hafler
David A. Hafler is an American neurologist and immunologist, Edgerly Professor of Neurology at Yale, whose work established regulatory T cell dysfunction in multiple sclerosis and autoimmune disease.
Dean M. Wingerchuk
Dean M. Wingerchuk is a neurologist and Chair of Neurology at Mayo Clinic in Arizona, known for the diagnostic criteria that defined NMOSD as distinct from multiple sclerosis.
Douglas L. Arnold
Douglas L. Arnold is a neurologist and MRI researcher at the Montreal Neurological Institute known for imaging research in multiple sclerosis and drug development, including ocrelizumab trials.
Elliot M. Frohman
Elliot M. Frohman is an American neurologist and neuroimmunologist specializing in multiple sclerosis, who founded the MS program at UT Southwestern and led its optical coherence tomography research.
Eva Lucille Feldman
Eva Lucille Feldman is an American neurologist and physician-scientist at Michigan Medicine known for research on ALS prevention, diabetic neuropathy, and stem cell therapy trials.
Frauke Zipp
Frauke Zipp is a German neurologist and neuroimmunologist, professor and director of neurology at University Medical Center Mainz since 2009, known for multiple sclerosis research.
Frederik Barkhof
Frederik Barkhof is a Dutch neuroradiologist known for the Barkhof criteria, MRI findings used to diagnose multiple sclerosis, and professor at Amsterdam UMC and University College London.
Gavin Giovannoni
Gavin Giovannoni is a British neurologist at Queen Mary University of London, known for championing the Epstein-Barr virus as a cause of multiple sclerosis and defining the NEDA treatment target.
George C. Ebers
George C. Ebers, born 1946 in Budapest, Hungary, is a Canadian neurologist who showed a major genetic component in multiple sclerosis susceptibility and led the 1986 Canadian twin study.
Giancarlo Comi
Giancarlo Comi (1947–2024) was an Italian neurologist and multiple sclerosis researcher who led defining phase 3 trials, co-founded the European Charcot Foundation, and won the 2015 Charcot Award.
Gianvito Martino
Gianvito Martino is an Italian neurologist and neuroimmunologist, born 1962 in Bergamo, who studies stem cell therapies for multiple sclerosis and led the first neural stem cell trial.
Hans Lassmann
Hans Lassmann, born 1949 in Vienna, is an Austrian neuroimmunologist and neuropathologist who classified multiple sclerosis lesions into four demyelination patterns and founded the Center for Brain Research in Vienna.
Hans‐Peter Hartung
Hans-Peter Hartung, born 1954, is a German neurologist and neuroimmunologist who led the Düsseldorf neurology department from 2001 to 2020 and led the 2002 mitoxantrone trial for progressive multiple sclerosis.
Hartmut Wekerle
Hartmut Wekerle, born 1944, is a German neuroimmunologist regarded as the founder of experimental neuroimmunology in Germany, known for T-cell autoimmunity research in multiple sclerosis.